Senior MedTech R&D Engineer - Frontline Device Innovation

Life Science Recruitment; Galway; On-site; EUR 70,000 - 100,000; Full time

Job summary

Ceroflo Ltd. is seeking a Senior R&D Engineer to drive the design and development of innovative medical devices in an early-stage startup environment.

You will translate design inputs into robust concepts, select materials and methods, and rigorously test prototypes while reporting progress to peers and management. The role requires a 5+ year track record in medical device design, strong fundamental engineering knowledge, and the ability to work independently in a fast-paced setting.

Qualifications

• Honours degree in Mechanical or Biomedical Engineering.
• Minimum of 5 years’ experience in all stages of medical device design and development.
• Strong design and technical ability with broad engineering knowledge.
• Strong work ethic with creative problem solving and ability to work on own initiative.

Responsibilities

• Translate design inputs into concepts, designs, specifications, and test plans.
• Select materials, assembly methods and process settings to improve performance and manufacturability.
• Develop and evaluate test models for prototype performance, executing test plans and protocols.
• Analyse test results and document findings to identify optimal solutions.

Skills

Creative problem solving

Independent work

Strong design ability

Engineering fundamentals

Education

Honours degree in Mechanical or Biomedical Engineering

Tools

CAD

Prototyping

Testing

Job description

Ceroflo Ltd. is seeking a Senior R&D Engineer to drive the design and development of innovative medical devices in an early-stage startup environment.

You will translate design inputs into robust concepts, select materials and methods, and rigorously test prototypes while reporting progress to peers and management. The role requires a 5+ year track record in medical device design, strong fundamental engineering knowledge, and the ability to work independently in a fast-paced setting.